{"id":"https://openalex.org/W3177241069","doi":"https://doi.org/10.3389/fphar.2021.687926","title":"Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency","display_name":"Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency","publication_year":2021,"publication_date":"2021-06-23","ids":{"openalex":"https://openalex.org/W3177241069","doi":"https://doi.org/10.3389/fphar.2021.687926","mag":"3177241069","pmid":"https://pubmed.ncbi.nlm.nih.gov/34248637","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8262647"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2021.687926","doi":"https://doi.org/10.3389/fphar.2021.687926","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.687926","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.687926/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.687926/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005669715","display_name":"Dian Su","orcid":"https://orcid.org/0000-0003-4572-462X","observed_orcids":["https://orcid.org/0000-0003-4572-462X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dian Su","raw_affiliation_strings":["Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052044457","display_name":"Donglu Zhang","orcid":"https://orcid.org/0000-0001-8677-9737","observed_orcids":["https://orcid.org/0000-0001-8677-9737"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Donglu Zhang","raw_affiliation_strings":["Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005669715","https://openalex.org/A5052044457"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":7.1362,"has_fulltext":true,"cited_by_count":184,"citation_normalized_percentile":{"value":0.98297955,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"12","issue":null,"first_page":"687926","last_page":"687926"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9980000257492065},{"id":"https://openalex.org/keywords/linker-design","display_name":"linker design","score":0.9240000247955322},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9649999737739563},{"id":"https://openalex.org/keywords/adc-stability","display_name":"ADC stability","score":0.8330000042915344},{"id":"https://openalex.org/keywords/linker-length","display_name":"linker length","score":0.8240000009536743},{"id":"https://openalex.org/keywords/steric-hindrance","display_name":"steric hindrance","score":0.9800000190734863},{"id":"https://openalex.org/keywords/site-specific-conjugation","display_name":"site-specific conjugation","score":0.8029999732971191},{"id":"https://openalex.org/keywords/dose-fractionation","display_name":"dose fractionation","score":0.7739999890327454},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7450000047683716},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.31700000166893005}],"concepts":[{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.9060733318328857},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.8069771528244019},{"id":"https://openalex.org/C134066672","wikidata":"https://www.wikidata.org/wiki/Q1424639","display_name":"Payload (computing)","level":3,"score":0.7243229150772095},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6456661820411682},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5470477342605591},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5289668440818787},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4826272428035736},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4604744017124176},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4412713646888733},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.38249504566192627},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3412851095199585},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2586965262889862},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21533933281898499},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.15903517603874207},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13439500331878662},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11550045013427734},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C158379750","wikidata":"https://www.wikidata.org/wiki/Q214111","display_name":"Network packet","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2021.687926","doi":"https://doi.org/10.3389/fphar.2021.687926","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.687926","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.687926/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmid:34248637","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34248637","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8262647","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8262647/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:b6891c9304684267977e7dc6de5b940e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b6891c9304684267977e7dc6de5b940e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 12 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2021.687926","doi":"https://doi.org/10.3389/fphar.2021.687926","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.687926","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.687926/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3177241069.pdf","grobid_xml":"https://content.openalex.org/works/W3177241069.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1530999669","https://openalex.org/W1971738718","https://openalex.org/W1992175481","https://openalex.org/W2057680307","https://openalex.org/W2090057677","https://openalex.org/W2171903625","https://openalex.org/W2314772071","https://openalex.org/W2341089209","https://openalex.org/W2474017875","https://openalex.org/W2507318226","https://openalex.org/W2515327483","https://openalex.org/W2524928664","https://openalex.org/W2595349270","https://openalex.org/W2615326416","https://openalex.org/W2653696249","https://openalex.org/W2773984687","https://openalex.org/W2781864644","https://openalex.org/W2787698051","https://openalex.org/W2788615048","https://openalex.org/W2793463849","https://openalex.org/W2808751881","https://openalex.org/W2888346227","https://openalex.org/W2936267551","https://openalex.org/W2965572865","https://openalex.org/W2966490622","https://openalex.org/W2999886821","https://openalex.org/W3003913151","https://openalex.org/W3020107077","https://openalex.org/W3046413935","https://openalex.org/W3048887723","https://openalex.org/W3085146133","https://openalex.org/W3093149563","https://openalex.org/W3136196685","https://openalex.org/W6631875626"],"related_works":["https://openalex.org/W7155057760","https://openalex.org/W7172325361","https://openalex.org/W166778795","https://openalex.org/W2783629021","https://openalex.org/W3150595399","https://openalex.org/W4410837017","https://openalex.org/W2592514789","https://openalex.org/W2788615048","https://openalex.org/W7170201509","https://openalex.org/W4409441875"],"abstract_inverted_index":{"The":[0,116],"development":[1,91],"of":[2,17,92,125,150],"antibody-drug":[3,129],"conjugates":[4,130],"(ADCs)":[5],"has":[6],"significantly":[7],"been":[8,119],"advanced":[9],"in":[10,31,35,43,112,152],"the":[11,15,36,44,123],"past":[12],"decade":[13],"given":[14],"improvement":[16],"payloads,":[18],"linkers":[19],"and":[20,39,53,73,77,82,105],"conjugation":[21,65],"methods.":[22],"In":[23],"particular,":[24],"linker":[25,61,71,74,96],"design":[26,97,124],"plays":[27],"a":[28,100],"critical":[29],"role":[30],"modulating":[32],"ADC":[33,49,103],"stability":[34,104],"systemic":[37],"circulation":[38],"payload":[40,106],"release":[41,107],"efficiency":[42,108],"tumors,":[45],"which":[46],"thus":[47],"affects":[48],"pharmacokinetic":[50],"(PK),":[51],"efficacy":[52,83,111],"toxicity":[54],"profiles.":[55,84],"Previously,":[56],"we":[57,86],"have":[58,118],"investigated":[59],"key":[60],"parameters":[62],"such":[63],"as":[64],"chemistry":[66],"(e.g.,":[67],"maleimide":[68],"vs.":[69],"disulfide),":[70],"length":[72],"steric":[75],"hindrance":[76],"their":[78],"impacts":[79],"on":[80,90],"PK":[81],"Herein,":[85],"discuss":[87],"our":[88],"perspectives":[89],"integrated":[93],"strategies":[94,117],"for":[95,109,146],"to":[98,122,138,143],"achieve":[99],"balance":[101],"between":[102],"desired":[110],"antigen-expressing":[113],"xenograft":[114],"models.":[115,154],"successfully":[120],"applied":[121],"site-specific":[126],"THIOMAB":[127],"TM":[128],"(TDCs)":[131],"with":[132],"different":[133],"payloads.":[134],"We":[135],"also":[136],"propose":[137],"conduct":[139],"dose":[140],"fractionation":[141],"studies":[142],"gain":[144],"guidance":[145],"optimal":[147],"dosing":[148],"regimens":[149],"ADCs":[151],"pre-clinical":[153]},"counts_by_year":[{"year":2026,"cited_by_count":68},{"year":2025,"cited_by_count":38},{"year":2024,"cited_by_count":37},{"year":2023,"cited_by_count":24},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":7}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-07-05T00:00:00"}